HOME >> BIOLOGY >> NEWS
Oral contraceptives increase C-reactive protein, an infIammatory biomarker

April 9, 2003 (San Diego, CA) When women think about birth control, estrogen, and cardiovascular risk, they often assume that there are no answers. They would appear to be correct.

On the one hand, new pharmacological advancements have provided combination oral contraceptive (OC) formulations with lower-dose estrogen. These formulations have significantly less risk of cardiovascular adverse events compared to the older combined formulations with higher doses. They also provide excellent cycle control, a low incidence of breakthrough bleeding and spotting, and increased patient satisfaction.

On the other hand, the current generation progestins appear less safe than earlier formulations with respect to the risk of blood clotting. Moreover, recent studies have associated current oral contraceptive use with risks for ischemic stroke and myocardial infarction, impaired blood anticoagulant pathways, and increased cardiovascular reactivity. Thus, cardiovascular risk relating to consumption of oral contraceptives still remains.

C-reactive protein (CRP) is a protein in the body whose level increases when blood vessels become inflamed. Measuring cardiovascular risk is thought to be possible by assessing CRP levels. Previously published data has shown that blood levels of CRP are elevated many years before a first heart attack or stroke occurs. Accordingly, a team of researchers set out to investigate the association between current low-dose oral contraceptives and levels of plasma CRP.

A New Study

The authors of "Oral Contraceptive Use and Increased Plasma Concentration of C-reactive Protein" are Darlene M Dreon, DrPH; Joanne L Slavin, PhD; and Stephen D Phinney, MD, PhD, from Galileo Pharmaceuticals, Inc, Santa Clara, CA and the University of Minnesota, St. Paul, MN. They will present their findings at the American Physiological Society's upcoming conference, Experimental Biology 2003, being held April 11-15, 2003,
'"/>

Contact: Donna J. Krupa
djkrupa1@aol.com
American Physiological Society
9-Apr-2003


Page: 1 2 3

Related biology news :

1. Synthetic hormone used in contraceptives and HRT produces negative effects in monkey studies
2. Study suggests newer oral contraceptives may be less harmful for women smokers
3. USC study links historical increases in life span to lower childhood exposure to infection
4. Study narrows search for genes placing men at increased risk for prostate cancer
5. Rare mutations can significantly increase risk factor for heart disease
6. Gene changes linked to increased eye pressure may have implications for glaucoma therapy
7. Alterations in vitamin D receptor gene increase prostate, breast cancer risk
8. Study links high carbohydrate diet to increased breast cancer risk
9. Carnivore species are predicted to be at increased extinction risk from human population growth
10. DFG announces three percent budget increase
11. Animal research suggests plant estrogens in soy do not increase breast cancer risk

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: